Newman Dignan & Sheerar Inc’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.69M Sell
28,738
-64
-0.2% -$7.49K 0.71% 37
2026
Q1
$3.46M Sell
28,802
-618
-2% -$71.3K 0.73% 35
2025
Q4
$3.1M Sell
29,420
-15,275
-34% -$1.43M 0.65% 38
2025
Q3
$3.75M Sell
44,695
-1,239
-3% -$102K 0.81% 29
2025
Q2
$3.64M Sell
45,934
-1,051
-2% -$83.5K 0.84% 29
2025
Q1
$4.22M Sell
46,985
-4,035
-8% -$377K 1.15% 22
2024
Q4
$5.08M Sell
51,020
-840
-2% -$86.6K 1.3% 21
2024
Q3
$5.41M Sell
51,860
-769
-1% -$91.4K 1.29% 19
2024
Q2
$6.52M Sell
52,629
-173
-0.3% -$22.3K 1.68% 13
2024
Q1
$6.97M Sell
52,802
-64
-0.1% -$7.89K 1.86% 10
2023
Q4
$5.76M Buy
52,866
+2,745
+5% +$285K 1.74% 12
2023
Q3
$5.16M Sell
50,121
-1,404
-3% -$151K 1.69% 14
2023
Q2
$5.95M Sell
51,525
-1,163
-2% -$132K 1.84% 11
2023
Q1
$5.61M Sell
52,688
-964
-2% -$104K 1.8% 12
2022
Q4
$5.95M Sell
53,652
-35
-0.1% -$3.58K 1.97% 9
2022
Q3
$4.62K Buy
53,687
+10
+0% +$893 0.72% 14
2022
Q2
$4.89M Sell
53,677
-470
-0.9% -$41.7K 1.67% 14
2022
Q1
$4.44K Buy
54,147
+44
+0.1% +$3.47K 0.85% 16
2021
Q4
$4.15M Buy
54,103
+1,270
+2% +$101K 1.26% 16
2021
Q3
$3.97M Sell
52,833
-87
-0.2% -$6.62K 1.15% 15
2021
Q2
$4.12M Sell
52,920
-2,062
-4% -$153K 1.39% 14
2021
Q1
$4.04M Sell
54,982
-1,340
-2% -$98.8K 1.47% 16
2020
Q4
$4.4K Sell
56,322
-131
-0.2% -$10K 0.71% 16
2020
Q3
$4.47M Sell
56,453
-324
-0.6% -$25.4K 1.87% 13
2020
Q2
$4.28M Buy
56,777
+271
+0.5% +$20.4K 1.85% 15
2020
Q1
$4.42M Sell
56,506
-1,208
-2% -$94.9K 2.32% 10
2019
Q4
$5.01K Buy
57,714
+83
+0.1% +$6.82K 0.53% 14
2019
Q3
$4.63M Sell
57,631
-1,279
-2% -$103K 2.18% 10
2019
Q2
$4.71K Sell
58,910
-638
-1% -$48.9K 0.13% 11
2019
Q1
$4.73M Sell
59,548
-1,486
-2% -$111K 1.9% 12
2018
Q4
$4.45K Sell
61,034
-309
-0.5% -$21.8K 0.38% 18
2018
Q3
$4.16M Sell
61,343
-249
-0.4% -$15.9K 1.82% 15
2018
Q2
$3.57K Buy
61,592
+141
+0.2% +$7.96K 0.24% 16
2018
Q1
$3.35M Sell
61,451
-5,726
-9% -$309K 1.69% 15
2017
Q4
$3.61M Buy
67,177
+409
+0.6% +$22.7K 1.8% 13
2017
Q3
$4.08M Buy
66,768
+9
+0% +$546 2.17% 10
2017
Q2
$4.08M Sell
66,759
-635
-0.9% -$38.7K 2.27% 9
2017
Q1
$4.09K Buy
67,394
+517
+0.8% +$31.4K 1.81% 13
2016
Q4
$3.76M Buy
66,877
+59
+0.1% +$3.45K 2.29% 9
2016
Q3
$3.98M Sell
66,818
-174
-0.3% -$10.2K 2.5% 6
2016
Q2
$3.68M Sell
66,992
-505
-0.7% -$26.9K 2.3% 8
2016
Q1
$3.41M Buy
67,497
+1,068
+2% +$52.3K 2.48% 6
2015
Q4
$3.35M Buy
66,429
+2,944
+5% +$148K 2.36% 7
2015
Q3
$2.99M Buy
63,485
+9,142
+17% +$486K 1.92% 8
2015
Q2
$2.95M Buy
54,343
+1,209
+2% +$67.8K 2.13% 8
2015
Q1
$2.91M Sell
53,134
-835
-2% -$47.3K 2.08% 8
2014
Q4
$2.92K Buy
53,969
+548
+1% +$30.5K 1.75% 10
2014
Q3
$3.02M Sell
53,421
-202
-0.4% -$11.3K 2.27% 8
2014
Q2
$2.96K Sell
53,623
-1,570
-3% -$85.6K 1.69% 12
2014
Q1
$2.99M Buy
55,193
+174
+0.3% +$9.01K 2.13% 8
2013
Q4
$2.63K Buy
55,019
+247
+0.5% +$11.3K 0.13% 10
2013
Q3
$2.49M Buy
54,772
+1,078
+2% +$49.2K 1.93% 9
2013
Q2
$2.38K Buy
+53,694
New +$2.4M 0.18% 12

Other funds holding MRK

Newman Dignan & Sheerar Inc's MRK Position: Q2 2026 in Review

Newman Dignan & Sheerar Inc reduced its Merck (MRK) stake by 0.22% in Q2 2026, selling an estimated $7.49K and leaving 28,738 shares worth $3.69M. The position accounts for 0.71% of the portfolio, ranked #37.

Newman Dignan & Sheerar Inc first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $6.97M in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Newman Dignan & Sheerar Inc held 28,738 shares of Merck worth $3.69M as of Q2 2026.
  • Newman Dignan & Sheerar Inc sold 64 Merck shares in Q2 2026, an estimated $7.49K.
  • Merck made up 0.71% of Newman Dignan & Sheerar Inc's portfolio in Q2 2026, its #37 holding.
  • Newman Dignan & Sheerar Inc first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • Newman Dignan & Sheerar Inc's Merck position peaked at $6.97M in Q1 2024.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Newman Dignan & Sheerar Inc's 13F filing for Q2 2026, filed 14 Jul 2026.